Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma

Ishani Das, Huiqin Chen, Gianluca Maddalo, Rainer Tuominen, Vito W. Rebecca, Meenhard Herlyn, Johan Hansson, Michael A. Davies, Suzanne Egyházi Brage

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences